참고문헌 (55)

1. Ahmadi Badi, S., Moshiri, A., Fateh, A., Rahimi Jamnani, F., Sarshar, M., Vaziri, F. and Siadat, S. D. 2017. Microbiota-derived extracellular vesicles as new systemic regulators. Front. Microbiol. 8, 1610. doi: 10.3389/fmicb.2017.01610. 

   상세보기

2. Ashrafian, F., Behrouzi, A., Shahriary, A., Ahmadi Badi, S., Davari, M., Khatami, S., Rahimi Jamnani, F., Fateh, A., Vaziri, F. and Siadat, S. D. 2019. Comparative study of effect of Akkermansia muciniphila and its extracellular vesicles on toll-like receptors and tight junction. Gastroenterol. Hepatol. Bed. Bench. 12, 163-168. 

3. Ashrafian, F., Shahriary, A., Behrouzi, A., Moradi, H. R., Keshavarz Azizi Raftar, S., Lari, A., Hadifar, S., Yaghoubfar, R., Ahmadi Badi, S., Khatami, S., Vaziri, F. and Siadat, S. D. 2019. Akkermansia muciniphila-derived extracellular vesicles as a mucosal delivery Vector for amelioration of obesity in mice. Front. Microbiol. 10, 2155. doi: 10.3389/fmicb.2019.02155. eCollection 2019. 

   상세보기

4. Assimakopoulos, S. F., Triantos, C., Maroulis, I. and Gogos, C. 2018. The role of the gut barrier function in health and disease. Gastroenterol. Res. 11, 261-263. 

5. Bag, S., Ghosh, T. S. and Das, B. 2017. Faecalibacterium prausnitzii isolated from the gut of a healthy indian adult. Genome Announc. 5, doi:10.1128/genomeA.01286-17. PMC 5690339. PMID 29146862. 

   상세보기

6. Behrouzi, A., Vaziri, F., Rad, F. R., Amanzadeh, A., Fateh, A., Moshiri, Khatami, S. and Siadat, S. D. 2018. Comparative study of pathogenic and non-pathogenic Escherichia coli outer membrane vesicles and prediction of host-interactions with TLR signaling pathways. BMC Res. Notes 11, 539. doi: 10.1186/s13104-018-3648-3. 

   상세보기

7. Belkaid, Y. and Hand, T. W. 2014. Role of the microbiota in immunity and inflammation. Cell 157, 121-141. 

   상세보기

8. Belzer, C. and de Vos, W. M. 2012. Microbes inside-from diversity to function: the case of Akkermansia. ISME J. 6, 1449-1458. 

   상세보기

9. Brodmann, T., Endo, A., Gueimonde, M., Vinderola, G., Kneifel, W., de Vos, W. M., Salminen, S. and Gomez-Gallego, C. 2017. Safety of novel microbes for human consumption: practical examples of assessment in the European Union. Front. Microbiol. 8, 1725. doi: 10.3389/fmicb.2017.01725. 

   상세보기

10. Cani, P. D. and de Vos, W. M. 2017. Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front. Microbiol. 8. 1765. doi:org/10.3389/fmicb.2017.01765 

    상세보기

11. Delgado, S., Cabrera-Rubio, R., Mira, A., Suarez, A. and Mayo, B. 2013. Microbiological survey of the human gastric ecosystem using culturing and pyrosequencing methods. Microb. Ecol. 63, 763-772. 

12. Derrien, M., Vaughan, E. E., Plugge, C. M. and de Vos, W. M. 2004. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 54, 1469-1476. 

    상세보기

13. DeWeerdt, S. 2018. How baby's first microbes could be crucial to future health. Nature 555, S18-S19. 

14. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., de Vos, W. M. and Cani, P. D. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA. 110, 9066-9071. 

    상세보기

15. Foligne, B., Daniel, C. and Pot, B. 2013. Probiotics from research to market: the possibilities, risks and challenges. Curr. Opin. Microbiol. 16, 284-292. 

16. Graf, D., Di Cagno, R., Fak, F., Flint, H. J., Nyman, M., Saarela, M. and Watzl, B. 2015. Contribution of diet to the composition of the human gut microbiota. Microb. Ecol. Health Dis. 26, 26164. doi: 10.3402/mehd.v26.26164. 

    상세보기

17. Hold, G. L., Schwiertz, A., Aminov, R. I., Blaut, M. and Flint, H. J. 2003. Oligonucleotide probes that detect quantitatively significant groups of butyrate producing bacteria in human feces. Appl. Environ. Microbiol. 69, 4320-4324. 

    상세보기

18. Huang, X. L., Zhang, X., Fei, X. Y., Chen, Z. G., Hao, Y. P., Zhang, S., Zhang, M. M., Yu, Y. Q. and Yu, C. G. 2016. Faecalibacterium prausnitzii supernatant ameliorates dextran sulfate sodium induced colitis by regulating Th17 cell differentiation. World J. Gastroenterol. 22, 5201-5210. 

    상세보기

19. Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T. and Zhang, C. 2019. Alteration of gut microbiota in inflammatory bowel disease(IBD): cause or consequence? IBD treatment targeting the gut microbiome. Pathogens 8, 126. doi: 10.3390/pathogens8030126. 

    상세보기

20. Konig, J., Wells, J., Cani, P. D., Garcia-Rodenas, C. L., Macdonald, T., Mercenier, A., Whyte, J., Troost, F. and Brummer, R. J. 2016. Human intestinal barrier function in health and disease. Clin. Transl. Gastroenterol. 7, e196. doi: 10.1038/ctg. 

    상세보기

21. Mantziari, A., Salminen, S., Szajewska, H. and Malagon-Rojas, J. N. 2020. Postbiotics against pathogens commonly involved in pediatric infectious diseases. Microorganisms 8, 1510. doi: 10.3390/microorganisms8101510. 

    상세보기

22. Martens, E. C., Neumann, M. and Desai, M. S. 2018. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat. Rev. Microbiol. 16, 457-470. 

    상세보기

23. Miquel, S., Beaumont, M., Martin, R., Langella, P., Braesco, V. and Thomas, M. 2015. A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe. Microb. Cell Fact. 14, 48. doi: 10.1186/s12934-015-0229-1. 

    상세보기

24. Moreno-Indias, I., Cardona, F., Tinahones, F. J. and Queipo-Ortuno, M. I. 2014. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front. Microbiol. 5, 190. doi: 10.3389/fmicb.2014.00190. 

    상세보기

25. Nataraj, B. H., Ali, S. A., Behare, P. V. and Yadav, H. 2020. Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods. Microb. Cell Fact. 19, 168. doi: 10.1186/s12934-020-01426-w. 

    상세보기

26. O'Toole, P. W., Marchesi, J. R. and Hill, C. 2017. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol. 25, 17057. doi: 10.1038/nmicrobiol.2017.57. 

    상세보기

27. Ottman, N., Huuskonen, L., Reunanen, J., Boeren, S., Klievink, J., Smidt, H., Belzer, C. and de Vos, W. M. 2016. Characterization of outer membrane proteome of Akkermansia muciniphila reveals sets of novel proteins exposed to the human intestine. Front. Microbiol. 7, 1157. doi: 10.3389/fmicb.2016.01157. 

    상세보기

28. Patterson, E., Ryan, P. M., Cryan, J. F., Dinan, T. G., Ross, R. P., Fitzgerald, G. F. and Stanton, C. 2016. Gut microbiota, obesity and diabetes. Postgrad. Med. J. 92, 286-300. 

    상세보기

29. Pique, N., Berlanga, M. and Minana-Galbis, D. 2019. Health benefts of heat-killed (Tyndallized) probiotics: an overview. Int. J. Mol. Sci. 20, 2534. doi: 10.3390/ijms20102534. 

    상세보기

30. Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N. and Duparc, T. 2017. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat. Med. 23, 107-113. 

    상세보기

31. Rajilic-Stojanovic, M., Biagi, E., Heilig, H. G., Kajander, K., Kekkonen, R. A., Tims, S. and de Vos, W. M. 2011. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792-1801. 

32. Reichardt, N., Duncan, S. H., Young, P., Belenguer, A., McWilliam, L. C., Scott, K. P., Flint, H. J. and Louis, P. 2014. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 8, 1323-1335. 

    상세보기

33. Richards, L. B., Li, M., van Esch, B. C. A. M., Garssen, J. and Folkerts, G. 2016. The effects of short chain fatty acids on the cardiovascular system. Pharma. Nutr. 4, 68-111. 

34. Ruiz, L., Delgado, S., Ruas-Madiedo, P., Sanchez, B. and Margolles, A. 2017. Bifidobacteria and their molecular communication with the immune system. Front. Microbiol. 8, 2345. doi: 10.3389/fmicb.2017.02345. 

    상세보기

35. Russo, E., Giudici, F., Fiorindi, C., Ficari, F., Scaringi, S. and Amedei, A. 2019. Immunomodulating activity and therapeutic effects of short chain fatty acids and tryptophan postbiotics in inflammatory bowel disease. Front. Immunol. 10, 2754. doi: 10.3389/fimmu.2019.02754. eCollection 2019. 

    

36. Sanders, M. E., Lenoir-Wijnkoop, I., Salminen, S., Merenstein, D. J., Gibson, G. R., Petschow, B. W., Nieuwdorp, M., Tancredi, D. J., Cifelli, C. J., Jacques, P. and Pot, B. 2014. Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann. N. Y. Acad. Sci. 1309, 19-29. 

    상세보기

37. Scheiman, J., Luber, J. M., Chavkin, T. A., MacDonald, T., Tung, A., Pham, L. D., Wibowo, M. C., Wurth, R. C., Punthambaker, S., Tierney, B. T., Yang, Z., Hattab, M. W., Avila-Pacheco, J., Clish, C. B., Lessard, S., Church, G. M. and Kostic, A. D. 2019. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat. Med. 25, 1104-1109. 

38. Schulz, E., Goes, A., Garcia, R., Panter, F., Koch, M., Muller, R., Fuhrmann, K. and Fuhrmann, G. 2018. Biocompatible bacteria-derived vesicles show inherent antimicrobial activity. J. Control. Release. 290, 46-55. 

    상세보기

39. Singh, A., Vishwakarma, V. and Singhal, B. 2018. Metabiotics: the functional metabolic signatures of probiotics: current state-of-art and future research priorities-metabiotics: probiotics efector molecules. Adv. Biosci. Biotechnol. 9, 720-726. 

40. Sommer, F. and Backhed, F. 2013. The gut microbiota- masters of host development and physiology. Nat. Rev. Microbiol. 11, 227-238. 

    상세보기

41. Song, H., Yoo, Y., Hwang, J., Na, Y. C. and Kim, H. S. 2016. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. J. Allergy Clin. Immunol. 137, 852-860. 

    상세보기

42. Soverini, M., Turroni, S., Biagi, E., Quercia, S., Brigidi, P., Candela, M. and Rampelli, S. 2017. Variation of carbohydrate-active enzyme patterns in the gut microbiota of Italian healthy subjects and Type 2 Diabetes Patients. Front. Microbiol. 8, 2079. doi: 10.3389/fmicb.2017.02079. 

    상세보기

43. Tap, J., Mondot, S., Levenez, F., Pelletier, E., Caron, C., Furet, J. P., Ugarte, E., Munoz-Tamayo, R., Paslier, D. L., Nalin, R., Dore, J. and Leclerc, M. 2009. Towards the human intestinal microbiota phylogenetic core. Environ. Microbiol. 11, 2574-2584. 

44. The human microbiome project consortium. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214. 

    상세보기

45. Toyofuku, M., Nomura, N. and Eberl, L. 2019. Types and origins of bacterial membrane vesicles. Nat. Rev. Microbiol. 17, 13-24. 

    상세보기

46. Tuohy, K. M. and Scott, K. P. 2015. "The microbiota of the human gastrointestinal tract: a molecular view" in diet-microbe interactions in the gut. pp. 1-15. Tuohy, K. M. and Del Rio, D. (eds.), Elsevier, London. 

47. Turner, J. R. 2009. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 9, 799-809. 

    상세보기

48. Ueno, N., Fujiya, M., Segawa, S., Nata, T., Moriichi, K., Tanabe, H., Mizukami, Y., Kobayashi, N., Ito, K. and Kohgo, Y. 2011. Heat-killed body of Lactobacillus brevis SBC8803 ameliorates intestinal injury in a murine model of colitis by enhancing the intestinal barrier. Infamm. Bowel. Dis. 17, 2235-2250. 

49. Viana, S. D., Nunes, S. and Reis, F. 2020. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities-Role of gut microbiota dysbiosis. Ageing Res. Rev. 62, 101123. doi: 10.1016/j.arr.2020.101123. 

    상세보기

50. Walker, A. W., Duncan, S. H., Louis, P. and Flint, H. J. 2014. Phylogeny, culturing, and metagenomics of the human gut microbiota. Trends Microbiol. 22, 267-274. 

51. Zhang, T., Li, Q., Cheng, L., Buch, H. and Zhang, F. 2019. Akkermansia muciniphila is a promising probiotic. Microb. Biotechnol. 12, 1109-1125. 

52. Zhou, L., Zhang, M., Wang, Y., Dorfman, R. G., Liu, H., Yu, T., Chen, X., Tang, D., Xu, L., Yin, Y., Pan, Y., Zhou, Q., Zhou, Y. and Yu, C. 2018. Faecalibacterium prausnitzii produces butyrate to maintain Th17/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1. Inflamm. Bowel. Dis. 24, 1926-1940. 

53. Zoetendal, E. G., Raes, J., van den Bogert, B., Arumugam, M., Booijink, C. C., Troost, F. J., Bork, P., Wels, M., de Vos, W. M. and Kleerebezem, M. 2012. The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J. 6, 1415-1426. 

    상세보기

54. Zolkiewicz, J., Marzec, A., Ruszczynski, M. and Feleszko, W. 2020. Postbiotics-a step beyond pre- and probiotics. Nutrients 12, 2189. doi: 10.3390/nu12082189. 

    상세보기

55. Zuo, T., Liu, Q., Zhang, F., Lui, G. C., Tso, E. Y., Yeoh, Y. K., Chen, Z., Boon, S. S., Chan, F. K., Chan, P. K. and Ng, S. C. 2020. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut 70, 276-284. 

저자의 다른 논문 :

최인순 (48) 이상원 (62)